Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 670 across all filing types
Latest filing 2025-04-02 Proxy Solicitation & In…
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Postal Ballot notice dated March 26, 2025
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice dated March 26, 2025, dispatched to shareholders for approval of a material related party transaction involving the company and its step-down subsidiary. It references compliance with SEBI Listing Regulations and the Companies Act, 2013, and details the voting period and resolution to be passed by shareholders via postal ballot. The document is a notice informing shareholders about the voting process and the resolution to be approved, not the results of the vote or a report of the meeting. It is not a full report like an Annual Report or Interim Report, nor is it a proxy solicitation or voting results announcement. The document is an official notice related to shareholder voting via postal ballot, which fits the category of Proxy Solicitation & Information Statement (PSI).
2025-04-02 English
Intimation about re-appointment of Independent Director
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to a stock exchange (BSE Limited) informing about the re-appointment of an Independent Director, Ms. Rajashri Ojha, for a second term of three years starting April 1, 2025. It references prior intimations and includes an annexure with details about the director's profile and appointment terms. The content focuses solely on management changes and director re-appointment disclosures, with no financial data, earnings, or report attachments. The document length is 3070 characters, which is relatively short and consistent with a management or board announcement rather than a full report. Therefore, this document fits the category of Board/Management Information (MANG).
2025-04-01 English
Notice for closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window pursuant to SEBI regulations and company code of conduct for insider trading. It informs about the trading restrictions around the declaration of quarterly and annual financial results but does not contain any financial data or results itself. The document is short (2523 characters) and serves as an announcement related to regulatory compliance and trading restrictions rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Datla
Major Shareholding Notification Classification · 100% confidence The document is a disclosure made pursuant to Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of equity shares by a promoter, including before and after shareholding percentages, mode and date of acquisition, and share capital details. This type of filing is a notification of a change in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a report, presentation, or announcement of voting results, but a regulatory disclosure of share acquisition. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2025-03-28 English
Disclosure in terms of Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Major Shareholding Notification Classification · 95% confidence The document is a disclosure made pursuant to Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of equity shares by a promoter, including shareholding percentages before and after the acquisition, mode of acquisition, and dates. The document is addressed to the stock exchange and is a formal notification of a change in substantial shareholding. It does not contain financial statements, management discussion, or other report content. This fits the definition of a Major Shareholding Notification (MRQ). The document length is about 4820 characters, which is sufficient for a detailed notification but not a full report. Therefore, the correct classification is MRQ with high confidence.
2025-03-28 English
Company has been honoured with "Pride of Maharashtra 2025 - Best Innovation of the Year Award in the Manufacturing Sector"
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Fermenta Biotech Limited has been honored with an innovation award for their product VITADEE Green. It is addressed to the stock exchange under SEBI regulations and includes details about the award, the product, and company background. There are no financial statements, quarterly or annual results, or detailed financial data. The document is a corporate announcement about an award and innovation recognition, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is also not a report publication announcement since it is not announcing the release of a report but rather a press release about an award. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement under SEBI regulations that does not fit other specific categories.
2025-03-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.